Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human APP/Protease Nexin II (Research Grade Aducanumab Biosimilar) Antibody, R&D Systems™

Human Monoclonal Antibody
$227.50 - $538.00
Specifications
| Antigen | APP |
|---|---|
| Clone | Hu15 |
| Dilution | Flow Cytometry 0.25 μg/106 cells, CyTOF-ready |
| Applications | Flow Cytometry, CyTOF |
| Classification | Monoclonal |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
MAB9710SP
![]() |
R&D Systems
MAB9710SP |
25 μg |
Each for $227.50
|
|
|||||
MAB9710100
![]() |
R&D Systems
MAB9710100 |
100 μg |
Each for $538.00
|
|
|||||
Description
APP Monoclonal specifically detects APP in Human samples. It is validated for Flow Cytometry, CyTOF-ready.Specifications
| APP | |
| Flow Cytometry 0.25 μg/106 cells, CyTOF-ready | |
| Monoclonal | |
| Human | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
| 351 | |
| IgG1 | |
| Protein A or G purified from cell culture supernatant | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution. |
| Hu15 | |
| Flow Cytometry, CyTOF | |
| Unconjugated | |
| Human | |
| Amyloid beta, amyloid beta (A4) precursor protein-binding, family B, member 2, amyloid beta A4 precursor protein-binding family B member 2, Amyloid beta precursor protein, APP, beta Amyloid, Protease Nexin II | |
| Human APP/Protease Nexin II | |
| Primary | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Detects human APP/Protease Nexin II based on Aducanumab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Aducanumab. This product is for research use only. |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title